WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), an international full service contract research organization (CRO) that provides comprehensive clinical solutions for pharmaceutical, biotechnology and medical device companies, and AtCor Medical Holdings Limited (ASX:ACG), the developer and marketer of the SphygmoCor system which measures central blood pressures non-invasively, today announced a joint marketing agreement for products and services that is anticipated to strengthen the fundamental value offerings of both companies.
